{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:33:38Z","timestamp":1790015618900,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3846,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/labinvest.2012.75","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T08:44:54Z","timestamp":1335170694000},"page":"1020-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function"],"prefix":"10.1016","volume":"92","author":[{"given":"Astrid","family":"Spruss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giridhar","family":"Kanuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan C","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Bergheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2012.75_bib1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/jhep.2001.28054","article-title":"Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology","volume":"34","author":"Yang","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2012.75_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2012.75_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2012.75_bib4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J Nutr"},{"key":"10.1038\/labinvest.2012.75_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","article-title":"Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction","volume":"45","author":"Ackerman","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/labinvest.2012.75_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clinbiochem.2005.01.013","article-title":"Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats","volume":"38","author":"Armutcu","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1038\/labinvest.2012.75_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2012.75_bib8","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/oby.2005.136","article-title":"Consuming fructose-sweetened beverages increases body adiposity in mice","volume":"13","author":"Jurgens","year":"2005","journal-title":"Obes Res"},{"key":"10.1038\/labinvest.2012.75_bib9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 7","key":"10.1038\/labinvest.2012.75_bib10","first-page":"57","article-title":"Therapy of nonalcoholic fatty liver disease: current status","volume":"60","author":"Duvnjak","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1038\/labinvest.2012.75_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ijo.2010.40","article-title":"Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study","volume":"34","author":"Garinis","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1038\/labinvest.2012.75_bib12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/oby.2010.21","article-title":"Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program","volume":"18","author":"Krakoff","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1038\/labinvest.2012.75_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5448.2008.00450.x","article-title":"Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents","volume":"10","author":"Nadeau","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1038\/labinvest.2012.75_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2012.75_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1053\/j.gastro.2006.03.020","article-title":"Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1","volume":"130","author":"Bergheim","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2012.75_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jnutbio.2010.04.007","article-title":"Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice","volume":"22","author":"Kanuri","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1038\/labinvest.2012.75_bib17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/oby.2009.58","article-title":"Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55","volume":"17","author":"Collison","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1038\/labinvest.2012.75_bib18","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1089\/ars.2010.3263","article-title":"Role of the inducible nitric oxide synthase (iNOS) in the onset of fructose-induced steatosis in mice","volume":"14","author":"Spruss","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1038\/labinvest.2012.75_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0b013e3181c7bdf1","article-title":"Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children","volume":"50","author":"Alisi","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1038\/labinvest.2012.75_bib20","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1194\/jlr.M007179","article-title":"Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice","volume":"51","author":"Volynets","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1038\/labinvest.2012.75_bib21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.23203","article-title":"Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure","volume":"50","author":"Chen","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2012.75_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2010.02.054","article-title":"Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions","volume":"1326","author":"Lischper","year":"2010","journal-title":"Brain Res"},{"key":"10.1038\/labinvest.2012.75_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jnutbio.2009.05.006","article-title":"Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Spruss","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.1038\/labinvest.2012.75_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2012.75_bib25","first-page":"176","article-title":"Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats","volume":"100","author":"Chen","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1038\/labinvest.2012.75_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/jpet.105.092122","article-title":"Metformin prevents endotoxin-induced liver injury after partial hepatectomy","volume":"316","author":"Bergheim","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/labinvest.2012.75_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/labinvest.2011.44","article-title":"Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells","volume":"91","author":"Kanuri","year":"2011","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2012.75_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1464-5491.1991.tb01610.x","article-title":"Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients","volume":"8","author":"Grant","year":"1991","journal-title":"Diabet Med"},{"key":"10.1038\/labinvest.2012.75_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-07-0815","article-title":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes","volume":"158","author":"Lund","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/labinvest.2012.75_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0002-9440(10)63888-6","article-title":"Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1","volume":"162","author":"Pandey","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2012.75_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","article-title":"High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis","volume":"18","author":"Sabate","year":"2008","journal-title":"Obes Surg"},{"key":"10.1038\/labinvest.2012.75_bib32","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2012.75_bib33","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2012.75_bib34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/oby.2009.464","article-title":"Effect of obesity on growth-related oncogene factor-alpha, thrombopoietin, and tissue inhibitor metalloproteinase-1 serum levels","volume":"18","author":"Maury","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1038\/labinvest.2012.75_bib35","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1210\/jc.2009-2623","article-title":"Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone","volume":"95","author":"Unal","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201275","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722013216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722013216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:39:42Z","timestamp":1758397182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722013216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0023683722013216"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2012.75","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2012.75","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2012.96","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}